AI assistant
Alkermes plc. — Director's Dealing 2022
Feb 23, 2022
31048_dirs_2022-02-23_9840c922-fb26-4657-a16c-2b9a950730fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2022-02-18
Reporting Person: Hopkinson Craig C. (EVP R&D, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-18 | Ordinary Shares | S | 2306 | $25.17 | Disposed | 9496 | Direct |
| 2022-02-20 | Ordinary Shares | M | 10096 | — | Acquired | 19592 | Direct |
| 2022-02-20 | Ordinary Shares | F | 2966 | $25.08 | Disposed | 16626 | Direct |
| 2022-02-21 | Ordinary Shares | M | 6875 | — | Acquired | 23501 | Direct |
| 2022-02-21 | Ordinary Shares | F | 2022 | $25.08 | Disposed | 21479 | Direct |
| 2022-02-22 | Ordinary Shares | M | 12037 | — | Acquired | 33516 | Direct |
| 2022-02-22 | Ordinary Shares | F | 3539 | $25.01 | Disposed | 29977 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-18 | Employee Stock Option (Right to Buy) | $25.08 | A | 139554 | Acquired | 2032-02-18 | Ordinary Shares (139554) | Direct |
| 2022-02-18 | Restricted Stock Unit Award | $0 | A | 34889 | Acquired | Ordinary Shares (34889) | Direct | |
| 2022-02-20 | Restricted Stock Unit Award | $0 | M | 10096 | Disposed | Ordinary Shares (10096) | Direct | |
| 2022-02-21 | Restricted Stock Unit Award | $0 | M | 6875 | Disposed | Ordinary Shares (6875) | Direct | |
| 2022-02-22 | Restricted Stock Unit Award | $0 | M | 12037 | Disposed | Ordinary Shares (12037) | Direct |
Footnotes
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: Restricted stock units convert into ordinary shares on a one-for-one basis.
F3: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023.
F4: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/18/2023.
F5: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021.
F6: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020.
F7: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022.